APA (7th ed.) Citation

CA, B., BJ, M., PR, L., DC, A., D, A., YM, A., . . . R, Z. (2026). Intermediate dose heparin thromboprophylaxis among critically ill patients with COVID-19: A randomized clinical trial. Journal of thrombosis and haemostasis : JTH, 24(7), 2492. https://doi.org/10.1016/j.jtha.2026.03.006

Chicago Style (17th ed.) Citation

CA, Bradbury, et al. "Intermediate Dose Heparin Thromboprophylaxis Among Critically Ill Patients with COVID-19: A Randomized Clinical Trial." Journal of Thrombosis and Haemostasis : JTH 24, no. 7 (2026): 2492. https://doi.org/10.1016/j.jtha.2026.03.006.

MLA (9th ed.) Citation

CA, Bradbury, et al. "Intermediate Dose Heparin Thromboprophylaxis Among Critically Ill Patients with COVID-19: A Randomized Clinical Trial." Journal of Thrombosis and Haemostasis : JTH, vol. 24, no. 7, 2026, p. 2492, https://doi.org/10.1016/j.jtha.2026.03.006.